Hong Kong—Dentons advised Union Medical Healthcare Limited, an aesthetic medical service provider in Hong Kong and Greater China which owns the brand DR REBORN, on its initial public offering and the related listing of its shares on the Hong Kong Stock Exchange. The offering consisted of a Hong Kong public offering and a concurrent Rule 144A/Reg S placement and raised aggregate gross proceeds of approximately US$96 million, excluding the over-allotment option. Credit Suisse acted as sole global coordinator, sole sponsor and joint bookrunner, andHaitong and CIMB acted as joint bookrunners, for the transaction.

The Dentons Hong Kong team was led by corporate partners Gordon Ng and Guangqin Wei, with support from corporate counsel Ignatius Seu, registered foreign lawyer Edward Leung and associate Shania Tsang, as well as tax partners John Harrington (Washington DC) and Timothy Santoli (New York) and corporate counsel Curtis Stefanak (New York).